Eye via TobiasD-206193/Pixabay
June 5, 2017 | Israeli startup Belkin Laser, a portfolio company of Israel’s RAD Biomed accelerator, has secured $5 million in funding from Zicom Holdings, Rimonci Capital and the European Union (grant). The capital raised adds to the $1.5 million previously raised by the company. Belkin Laser develops a laser device for glaucoma patients who will receive short, efficient treatments, instead of the eye drops used today. Belkin Laser was founded in 2013 under a license agreement from Israel’s Sheba Medical Center and Tel Aviv University. Its product is based on Prof. Michael Belkin’s invention. [Photo: TobiasD]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

UN Honors Israeli Food Exec For Sustainability Work
September 26, 2023

Startup Unveils Tech To Speed Up Growth Of Cultivated Meat
September 26, 2023

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Facebook comments